AKT1 and chronic myelogenous leukemia, BCR-ABL1 positive: Previous studies have shown that the tyrosine kinase BCR-ABL in CML cells activates multiple signal transduction pathways, including the PI3K/AKT signaling pathway, thereby inactivating FOXO transcription factors.